Compare Sterling Biotech with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs FULFORD INDIA - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH FULFORD INDIA STERLING BIOTECH/
FULFORD INDIA
 
P/E (TTM) x -0.4 398.8 - View Chart
P/BV x 0.0 6.2 0.2% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 STERLING BIOTECH   FULFORD INDIA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
FULFORD INDIA
Mar-14
STERLING BIOTECH/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs11942 1.1%   
Low Rs3450 0.8%   
Sales per share (Unadj.) Rs26.8691.4 3.9%  
Earnings per share (Unadj.) Rs-15.011.5 -130.5%  
Cash flow per share (Unadj.) Rs-5.515.4 -35.6%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.3 0.0%  
Book value per share (Unadj.) Rs54.9380.0 14.4%  
Shares outstanding (eoy) m267.873.90 6,868.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.0 25.8%   
Avg P/E ratio x-0.560.7 -0.8%  
P/CF ratio (eoy) x-1.345.3 -2.8%  
Price / Book Value ratio x0.11.8 6.9%  
Dividend payout %017.4 0.0%   
Avg Mkt Cap Rs m1,8622,714 68.6%   
No. of employees `0001.40.4 305.0%   
Total wages/salary Rs m547505 108.3%   
Avg. sales/employee Rs Th5,303.36,073.0 87.3%   
Avg. wages/employee Rs Th403.81,137.4 35.5%   
Avg. net profit/employee Rs Th-2,959.0100.7 -2,939.2%   
INCOME DATA
Net Sales Rs m7,1812,696 266.3%  
Other income Rs m43125 34.0%   
Total revenues Rs m7,2232,822 256.0%   
Gross profit Rs m947-46 -2,040.7%  
Depreciation Rs m2,54315 16,731.6%   
Interest Rs m4,37710 46,074.7%   
Profit before tax Rs m-5,93154 -10,922.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,92410 -20,044.8%   
Profit after tax Rs m-4,00745 -8,963.1%  
Gross profit margin %13.2-1.7 -766.3%  
Effective tax rate %32.417.7 183.5%   
Net profit margin %-55.81.7 -3,365.7%  
BALANCE SHEET DATA
Current assets Rs m14,3351,738 824.7%   
Current liabilities Rs m49,809545 9,144.3%   
Net working cap to sales %-494.044.3 -1,116.0%  
Current ratio x0.33.2 9.0%  
Inventory Days Days40348 832.3%  
Debtors Days Days1714 3,964.2%  
Net fixed assets Rs m55,43212 465,817.5%   
Share capital Rs m26839 686.9%   
"Free" reserves Rs m13,9351,443 965.7%   
Net worth Rs m14,7011,482 992.0%   
Long term debt Rs m9,4780-   
Total assets Rs m73,9882,077 3,562.8%  
Interest coverage x-0.46.7 -5.3%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.11.3 7.5%   
Return on assets %0.52.6 19.2%  
Return on equity %-27.33.0 -903.5%  
Return on capital %-6.44.3 -149.3%  
Exports to sales %25.90-   
Imports to sales %0.224.5 0.7%   
Exports (fob) Rs m1,860NA-   
Imports (cif) Rs m12659 1.9%   
Fx inflow Rs m1,86017 10,812.8%   
Fx outflow Rs m25673 3.7%   
Net fx Rs m1,835-656 -279.7%   
CASH FLOW
From Operations Rs m1,71990 1,909.7%  
From Investments Rs m-3,148105 -3,009.8%  
From Financial Activity Rs m1,426-14 -10,113.5%  
Net Cashflow Rs m-3181 -1.9%  

Share Holding

Indian Promoters % 33.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 3.8 -  
FIIs % 9.9 0.1 9,900.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 21.2 185.4%  
Shareholders   21,482 4,783 449.1%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   UNICHEM LAB  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  WOCKHARDT  VENUS REMEDIES  

Compare STERLING BIOTECH With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - BIOCON COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS